NCT05695521 - Regulatory T Cells for Amyotrophic Lateral Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2027

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL

CK0803

CK0803 (cryopreserved, allogeneic, cord blood derived T regulatory cells that express neurotropic homing markers) will be administered intravenously

OTHER

Excipient

Trial Locations (3)

Columbia University Irving Medical Center, New York

Baylor College of Medicine, Houston

Michael E. DeBakey Veterans Affairs Medical Center, Houston